Multiple Assemblies exist for SMTL entry 3eoa
Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I; X-RAY DIFFRACTION 2.80 Å

SMTL ID
3eoa.1
Ligands
-
Polypeptides
Efalizumab Fab fragment, light chain; Efalizumab Fab fragment, heavy chain; Integrin alpha-L
Oligo-state
hetero-oligomer
SMTL ID
3eoa.2
Ligands
-
Polypeptides
Efalizumab Fab fragment, light chain; Efalizumab Fab fragment, heavy chain; Integrin alpha-L
Oligo-state
hetero-oligomer